Tag: life sciences
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
-
Companies to Assess Ovarian Health Biotech Drug
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.
-
Long-Acting Drug Start-Up Raises $4M in Seed Funds
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds.
-
Trial Advances of Dual-Action Cancer Immunotherapy
A clinical trial assessing a synthetic antibody to generate an immediate response and also generate a more durable treatment for solid tumor cancers, advanced to a mid-stage study.
-
Digital Chemistry Start-Up Gains $43M in Early Funds
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round.
-
Companies Partner on Fast Production of Biologics in Plants
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities.
-
A.I. Analytics Detect Heart Failure in Single Ultrasound View
A system using deep learning algorithms to analyze ultrasound video images is shown to detect a difficult-to diagnose type of heart failure with clips from one view of the heart.
-
FDA Issues Guidance for Opioid Therapy Device Trials
The U.S. Food and Drug Administration issued new regulatory guidance for clinical trials of medical devices designed to prevent or treat opioid use disorder.
-
Streamlined Gene Therapy Delivery Process Demonstrated
A group of academic and industry researchers exhibited in lab cells and mice a more direct delivery technique that could make gene therapies more accessible and inexpensive.